CoChat

Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression

Open access
Yang, H, Pellegrini, L, Napolitano, A, Giorgi, C, Jube, S, Preti, A, Jennings, C J, De Marchis, F, Flores, E G, Larson, D, Pagano, I, Tanji, M, Powers, A, Kanodia, S, Gaudino, G, Pastorino, S, Pass, H I, Pinton, P, Bianchi, M E, Carbone, M · 2015 · Cell Death & Disease
Cited by 81

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

High-mobility group box 1 (HMGB1) is an inflammatory molecule that has a critical role in the initiation and progression of malignant mesothelioma (MM). Aspirin (acetylsalicylic acid, ASA) is the most widely used nonsteroidal anti-inflammatory drug that reduces the incidence, metastatic potential and mortality of many inflammation-induced cancers. We hypothesized that ASA may exert anticancer properties in MM by abrogating the carcinogenic effects of HMGB1. Using HMGB1-secreting and -non-secreting human MM cell lines, we determined whether aspirin inhibited the hallmarks of HMGB1-induced MM cell growth in vitro and in vivo. Our data demonstrated that ASA and its metabolite, salicylic acid (SA), inhibit motility, migration, invasion and anchorage-independent colony formation of MM cells via a novel HMGB1-mediated mechanism. ASA/SA, at serum concentrations comparable to those achieved in humans taking therapeutic doses of aspirin, and BoxA, a specific inhibitor of HMGB1, markedly reduced MM growth in xenograft mice and significantly improved survival of treated animals. The effects of ASA and BoxA were cyclooxygenase-2 independent and were not additive, consistent with both acting via inhibition of HMGB1 activity. Our findings provide a rationale for the well documented, yet poorly understood antitumorigenic activity of aspirin, which we show proceeds via HMGB1 inhibition. Moreover, the use of BoxA appears to allow a more efficient HMGB1 targeting while eluding the known gastrointestinal side effects of ASA. Our findings are directly relevant to MM. Given the emerging importance of HMGB1 and its tumor-promoting functions in many cancer types, and of aspirin in cancer prevention and therapy, our investigation is poised to provide broadly applicable information.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cddis.2015.153

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 81

Metadata

Authors
Yang, H., Pellegrini, L., Napolitano, A., Giorgi, C., Jube, S., Preti, A., Jennings, C. J., De Marchis, F., Flores, E. G., Larson, D., Pagano, I., Tanji, M., Powers, A., Kanodia, S., Gaudino, G., Pastorino, S., Pass, H. I., Pinton, P., Bianchi, M. E., & Carbone, M.
Venue
Cell Death & Disease
Published
2015-06-11
Volume
6
Issue
6
Pages
e1786-e1786
ISSN
2041-4889 (ISSN-L)
OpenAlex
W1532588118
Cited by
81
References
7
FWCI
5.69
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. https://app.cochat.ai/papers/10.1038/cddis.2015.153
The paper
Yang, H., Pellegrini, L., Napolitano, A., Giorgi, C., Jube, S., Preti, A., Jennings, C. J., De Marchis, F., Flores, E. G., Larson, D., Pagano, I., Tanji, M., Powers, A., Kanodia, S., Gaudino, G., Pastorino, S., Pass, H. I., Pinton, P., Bianchi, M. E., & Carbone, M. (2015). Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death & Disease. https://doi.org/10.1038/cddis.2015.153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.